{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:33:28Z","timestamp":1791401608187,"version":"4.3.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Al-Andalus Biopharma SL","award":["Al-Andalus Biopharma SL"],"award-info":[{"award-number":["Al-Andalus Biopharma SL"]}]},{"name":"Agencia Valenciana de Innovaci\u00f3n","award":["AVI-GVA COVID-19-068"],"award-info":[{"award-number":["AVI-GVA COVID-19-068"]}]},{"name":"Agencia Valenciana de Innovaci\u00f3n","award":["GVA-COVID19\/2021\/047"],"award-info":[{"award-number":["GVA-COVID19\/2021\/047"]}]},{"name":"Juvenile Diabetes Research Foundation","award":["JDRF 2-SRA-2019-837"],"award-info":[{"award-number":["JDRF 2-SRA-2019-837"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ICI21\/00016"],"award-info":[{"award-number":["ICI21\/00016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DTS19\/00175"],"award-info":[{"award-number":["DTS19\/00175"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009160","name":"Universit\u00e9 Toulouse III - Paul Sabatier","doi-asserted-by":"publisher","award":["FIS PI21\/01642"],"award-info":[{"award-number":["FIS PI21\/01642"]}],"id":[{"id":"10.13039\/501100009160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Institute of Health Carlos III","doi-asserted-by":"crossref","award":["PDC2022-133952-100"],"award-info":[{"award-number":["PDC2022-133952-100"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04289-3","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:45:33Z","timestamp":1743864333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Consecutive intrabronchial administration of Wharton\u2019s jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)"],"prefix":"10.1186","volume":"16","author":[{"given":"Nerea","family":"Dominguez-Pinilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ignacio","family":"Gonz\u00e1lez-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Gonzaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"L\u00f3pez Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Castellano Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro Gimeno","family":"Diaz de Atauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Salom\u00e9","family":"Albi Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mart\u00ednez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"I\u00f1iguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Serrano Garrote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena Castro","family":"Fronti\u00f1\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etelvina","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Gutierrez-Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Anton-Bonete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Martinez-Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Castillo-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Prat-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Morante Valverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Manuel","family":"Hern\u00e1ndez-Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Belda-Hofheinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernat","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"2","key":"4289_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.resp.2013.03.014","volume":"187","author":"SC Abreu","year":"2013","unstructured":"Abreu SC, et al. Bone marrow-derived mononuclear cells vs. mesenchymal stromal cells in experimental allergic asthma. Respir Physiol Neurobiol. 2013;187(2):190\u20138.","journal-title":"Respir Physiol Neurobiol"},{"issue":"4","key":"4289_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/ALN.0b013e318287ba08","volume":"118","author":"GF Curley","year":"2013","unstructured":"Curley GF, et al. Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury. Anesthesiology. 2013;118(4):924\u201332.","journal-title":"Anesthesiology"},{"key":"4289_CR3","doi-asserted-by":"crossref","unstructured":"Dutra Silva J et al. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS. Eur Respir J. 2021;58(1):2002978.","DOI":"10.1183\/13993003.02978-2020"},{"issue":"6","key":"4289_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/thoraxjnl-2011-201176","volume":"67","author":"N Gupta","year":"2012","unstructured":"Gupta N, et al. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Thorax. 2012;67(6):533\u20139.","journal-title":"Thorax"},{"issue":"1","key":"4289_CR5","doi-asserted-by":"publisher","first-page":"11728","DOI":"10.1038\/s41598-022-14846-y","volume":"12","author":"Y Mo","year":"2022","unstructured":"Mo Y, et al. Intratracheal administration of mesenchymal stem cells modulates lung macrophage polarization and exerts anti-asthmatic effects. Sci Rep. 2022;12(1):11728.","journal-title":"Sci Rep"},{"issue":"2","key":"4289_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/thoraxjnl-2017-211439","volume":"74","author":"JE Millar","year":"2019","unstructured":"Millar JE, et al. Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance. Thorax. 2019;74(2):194\u20136.","journal-title":"Thorax"},{"issue":"2","key":"4289_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.molmed.2018.12.006","volume":"25","author":"G Moll","year":"2019","unstructured":"Moll G, et al. Intravascular mesenchymal stromal\/stem cell therapy product diversification: time for new clinical guidelines. Trends Mol Med. 2019;25(2):149\u201363.","journal-title":"Trends Mol Med"},{"issue":"1","key":"4289_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/stcltm\/szab005","volume":"11","author":"G Moll","year":"2022","unstructured":"Moll G, et al. Improved MSC minimal criteria to maximize patient safety: A call to embrace tissue factor and hemocompatibility assessment of MSC products. Stem Cells Transl Med. 2022;11(1):2\u201313.","journal-title":"Stem Cells Transl Med"},{"key":"4289_CR9","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3389\/fimmu.2020.01091","volume":"11","author":"G Moll","year":"2020","unstructured":"Moll G, et al. MSC therapies for COVID-19: importance of patient coagulopathy, thromboprophylaxis, cell product quality and mode of delivery for treatment safety and efficacy. Front Immunol. 2020;11:1091.","journal-title":"Front Immunol"},{"issue":"1","key":"4289_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40635-019-0232-7","volume":"7","author":"JE Millar","year":"2019","unstructured":"Millar JE, et al. Extracorporeal membrane oxygenation (ECMO) and the acute respiratory distress syndrome (ARDS): a systematic review of pre-clinical models. Intensive Care Med Exp. 2019;7(1):18.","journal-title":"Intensive Care Med Exp"},{"key":"4289_CR11","doi-asserted-by":"publisher","first-page":"1200180","DOI":"10.3389\/fimmu.2023.1200180","volume":"14","author":"PS Couto","year":"2023","unstructured":"Couto PS, et al. Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety\/efficacy outcomes, cell product manufacturing and clinical delivery. Front Immunol. 2023;14:1200180.","journal-title":"Front Immunol"},{"key":"4289_CR12","doi-asserted-by":"publisher","first-page":"839844","DOI":"10.3389\/fimmu.2022.839844","volume":"13","author":"O Ringd\u00e9n","year":"2022","unstructured":"Ringd\u00e9n O, et al. Mesenchymal stromal cells for enhancing hematopoietic engraftment and treatment of Graft-Versus-Host disease, hemorrhages and acute respiratory distress syndrome. Front Immunol. 2022;13:839844.","journal-title":"Front Immunol"},{"key":"4289_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpeds.2017.02.061","volume":"185","author":"SY Ahn","year":"2017","unstructured":"Ahn SY, et al. Two-Year Follow-Up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia. J Pediatr. 2017;185:49\u2013e542.","journal-title":"J Pediatr"},{"issue":"5","key":"4289_CR14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","volume":"164","author":"YS Chang","year":"2014","unstructured":"Chang YS, et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014;164(5):966\u201372.e6.","journal-title":"J Pediatr"},{"issue":"3","key":"4289_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3346\/jkms.2014.29.3.438","volume":"29","author":"Y Chang","year":"2014","unstructured":"Chang Y, et al. Intratracheal administration of umbilical cord blood-derived mesenchymal stem cells in a patient with acute respiratory distress syndrome. J Korean Med Sci. 2014;29(3):438\u201340.","journal-title":"J Korean Med Sci"},{"issue":"5","key":"4289_CR16","doi-asserted-by":"publisher","first-page":"L688","DOI":"10.1152\/ajplung.00148.2020","volume":"320","author":"A Porzionato","year":"2021","unstructured":"Porzionato A, et al. Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2021;320(5):L688\u2013704.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"4289_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ejpb.2013.11.002","volume":"86","author":"P G\u00e1lvez-Mart\u00edn","year":"2014","unstructured":"G\u00e1lvez-Mart\u00edn P, et al. Study of the stability of packaging and storage conditions of human mesenchymal stem cell for intra-arterial clinical application in patient with critical limb ischemia. Eur J Pharm Biopharm. 2014;86(3):459\u201368.","journal-title":"Eur J Pharm Biopharm"},{"key":"4289_CR18","doi-asserted-by":"crossref","unstructured":"Sanchez-Diaz M et al. Biodistribution of mesenchymal stromal cells after administration in animal models and humans: A systematic review. J Clin Med. 2021;10(13):2925.","DOI":"10.3390\/jcm10132925"},{"issue":"1","key":"4289_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/s13063-021-05430-2","volume":"22","author":"B Soria-Juan","year":"2021","unstructured":"Soria-Juan B, et al. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial). Trials. 2021;22(1):595.","journal-title":"Trials"},{"issue":"5","key":"4289_CR20","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Pan\u00e9s","year":"2018","unstructured":"Pan\u00e9s J, et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2018;154(5):1334\u2013e13424.","journal-title":"Gastroenterology"},{"issue":"6","key":"4289_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s40259-018-0311-4","volume":"32","author":"LJ Scott","year":"2018","unstructured":"Scott LJ. Darvadstrocel: A review in Treatment-Refractory complex perianal fistulas in Crohn\u2019s disease. BioDrugs. 2018;32(6):627\u201334.","journal-title":"BioDrugs"},{"issue":"44","key":"4289_CR22","doi-asserted-by":"publisher","first-page":"e2308511120","DOI":"10.1073\/pnas.2308511120","volume":"120","author":"R Sender","year":"2023","unstructured":"Sender R, et al. The total mass, number, and distribution of immune cells in the human body. Proc Natl Acad Sci U S A. 2023;120(44):e2308511120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4289_CR23","first-page":"341","volume":"40","author":"Z Li","year":"2024","unstructured":"Li Z, et al. Clinical observation on the safety and efficacy of umbilical cord mesenchymal stem cells in the treatment of bronchiolitis obliterans after allogeneic Haematopoietic stem cell transplantation. Biotechnol Genet Eng Rev. 2024;40(1):341\u201358.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"4289_CR24","doi-asserted-by":"crossref","unstructured":"Pelizzo G et al. Mesenchymal stromal cells for the treatment of interstitial lung disease in children: A look from pediatric and pediatric surgeon viewpoints. Cells. 2021;10(12).","DOI":"10.3390\/cells10123270"},{"issue":"12","key":"4289_CR25","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S2213-2600(14)70217-6","volume":"2","author":"J Walter","year":"2014","unstructured":"Walter J, Ware LB, Matthay MA. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. Lancet Respir Med. 2014;2(12):1016\u201326.","journal-title":"Lancet Respir Med"},{"key":"4289_CR26","doi-asserted-by":"publisher","first-page":"100454","DOI":"10.1016\/j.eclinm.2020.100454","volume":"25","author":"F S\u00e1nchez-Guijo","year":"2020","unstructured":"S\u00e1nchez-Guijo F, et al. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine. 2020;25:100454.","journal-title":"EClinicalMedicine"},{"issue":"12","key":"4289_CR27","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.2337\/db13-0896","volume":"62","author":"L Acosta","year":"2013","unstructured":"Acosta L, et al. Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity. Diabetes. 2013;62(12):4266\u20139.","journal-title":"Diabetes"},{"key":"4289_CR28","doi-asserted-by":"crossref","unstructured":"Hernandez Pichardo A et al. Intravenous Administration of Human Umbilical Cord Mesenchymal Stromal Cells Leads to an Inflammatory Response in the Lung. Stem Cells Int. 2023;2023:7397819.","DOI":"10.1155\/2023\/7397819"},{"key":"4289_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fncel.2019.00204","volume":"13","author":"B Soria","year":"2019","unstructured":"Soria B, et al. Human mesenchymal stem cells prevent neurological complications of radiotherapy. Front Cell Neurosci. 2019;13:204.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"4289_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41423-023-01018-9","volume":"20","author":"C Giacomini","year":"2023","unstructured":"Giacomini C, et al. The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair. Cell Mol Immunol. 2023;20(6):570\u201382.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"4289_CR31","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53(1):e12712.","journal-title":"Cell Prolif"},{"key":"4289_CR32","doi-asserted-by":"publisher","first-page":"1089817","DOI":"10.3389\/fcell.2023.1089817","volume":"11","author":"CC Lachaud","year":"2023","unstructured":"Lachaud CC, et al. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses. Front Cell Dev Biol. 2023;11:1089817.","journal-title":"Front Cell Dev Biol"},{"key":"4289_CR33","doi-asserted-by":"publisher","first-page":"742088","DOI":"10.3389\/fcell.2021.742088","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Mesenchymal stem cell Immunomodulation: A novel intervention mechanism in cardiovascular disease. Front Cell Dev Biol. 2021;9:742088.","journal-title":"Front Cell Dev Biol"},{"key":"4289_CR34","doi-asserted-by":"publisher","first-page":"1408880","DOI":"10.3389\/fimmu.2024.1408880","volume":"15","author":"A Hirano","year":"2024","unstructured":"Hirano A, et al. Immunological characteristics of Bronchoalveolar lavage fluid and blood across connective tissue disease-associated interstitial lung diseases. Front Immunol. 2024;15:1408880.","journal-title":"Front Immunol"},{"key":"4289_CR35","doi-asserted-by":"crossref","unstructured":"Hogea P et al. Serum and Bronchoalveolar lavage fluid levels of cytokines in patients with lung cancer and chronic lung disease: A prospective comparative study. J Pers Med. 2023;13(6).","DOI":"10.3390\/jpm13060998"},{"issue":"8","key":"4289_CR36","first-page":"e66422","volume":"16","author":"ST Lira","year":"2024","unstructured":"Lira ST, et al. A systematic review on biomarkers: are there reliable molecular biomarkers in patients with rheumatoid Arthritis-Associated interstitial lung disease?? Cureus. 2024;16(8):e66422.","journal-title":"Cureus"},{"issue":"1","key":"4289_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s42358-022-00269-w","volume":"62","author":"C Lv","year":"2022","unstructured":"Lv C, et al. Serum MMP-9, SP-D, and VEGF levels reflect the severity of connective tissue disease-associated interstitial lung diseases. Adv Rheumatol. 2022;62(1):37.","journal-title":"Adv Rheumatol"},{"key":"4289_CR38","doi-asserted-by":"publisher","first-page":"1479458","DOI":"10.3389\/fimmu.2024.1479458","volume":"15","author":"M Suchankova","year":"2024","unstructured":"Suchankova M, et al. The Bronchoalveolar lavage fluid CD44 as a marker for pulmonary fibrosis in diffuse parenchymal lung diseases. Front Immunol. 2024;15:1479458.","journal-title":"Front Immunol"},{"issue":"11","key":"4289_CR39","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1097\/CM9.0000000000002171","volume":"136","author":"Q Wang","year":"2023","unstructured":"Wang Q, et al. Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis. Chin Med J (Engl). 2023;136(11):1278\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"4289_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcyt.2015.10.001","volume":"18","author":"I Oliver-Vila","year":"2016","unstructured":"Oliver-Vila I, et al. Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton\u2019s jelly. Cytotherapy. 2016;18(1):25\u201335.","journal-title":"Cytotherapy"},{"issue":"1","key":"4289_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2015.03.019","volume":"53","author":"BH Cohen","year":"2015","unstructured":"Cohen BH, et al. Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 phase I\/II study. A report from the children\u2019s oncology group. Pediatr Neurol. 2015;53(1):31\u201346.","journal-title":"Pediatr Neurol"},{"key":"4289_CR42","doi-asserted-by":"crossref","unstructured":"Peyrl A, et al. Sustained survival benefit in recurrent Medulloblastoma by a metronomic antiangiogenic regimen: A nonrandomized controlled trial. JAMA Oncol. 2023.","DOI":"10.1001\/jamaoncol.2023.4437"},{"key":"4289_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jpeds.2019.02.029","volume":"210","author":"SB Powell","year":"2019","unstructured":"Powell SB, Silvestri JM. Safety of intratracheal administration of human umbilical cord blood derived mesenchymal stromal cells in extremely low birth weight preterm infants. J Pediatr. 2019;210:209\u2013e2132.","journal-title":"J Pediatr"},{"issue":"8","key":"4289_CR44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/sctm.20-0330","volume":"10","author":"SY Ahn","year":"2021","unstructured":"Ahn SY, et al. Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial. Stem Cells Transl Med. 2021;10(8):1129\u201337.","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"4289_CR45","doi-asserted-by":"publisher","first-page":"L829","DOI":"10.1152\/ajplung.00347.2011","volume":"302","author":"KA Tropea","year":"2012","unstructured":"Tropea KA, et al. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012;302(9):L829\u201337.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4289_CR46","doi-asserted-by":"publisher","first-page":"215517901875943","DOI":"10.1177\/2155179018759434","volume":"10","author":"HC Lin","year":"2018","unstructured":"Lin HC, et al. Airway delivery of bone Marrow-Derived mesenchymal stem cells reverses bronchopulmonary dysplasia superimposed with acute respiratory distress syndrome in an infant. Cell Med. 2018;10:2155179018759434.","journal-title":"Cell Med"},{"issue":"3","key":"4289_CR47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jpedsurg.2016.11.031","volume":"52","author":"RJ Houmes","year":"2017","unstructured":"Houmes RJ, et al. Risk and relevance of open lung biopsy in pediatric ECMO patients: the Dutch experience. J Pediatr Surg. 2017;52(3):405\u20139.","journal-title":"J Pediatr Surg"},{"issue":"4","key":"4289_CR48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/thx.2003.010793","volume":"59","author":"D Inwald","year":"2004","unstructured":"Inwald D, et al. Open lung biopsy in neonatal and paediatric patients referred for extracorporeal membrane oxygenation (ECMO). Thorax. 2004;59(4):328\u201333.","journal-title":"Thorax"},{"key":"4289_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/5584_2015_187","volume":"885","author":"K Takeda","year":"2016","unstructured":"Takeda K, et al. Respiratory toxicity of dimethyl sulfoxide. Adv Exp Med Biol. 2016;885:89\u201396.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"4289_CR50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10753-016-0502-4","volume":"40","author":"YC Tsung","year":"2017","unstructured":"Tsung YC, et al. Dimethyl sulfoxide attenuates acute lung injury induced by hemorrhagic shock\/resuscitation in rats. Inflammation. 2017;40(2):555\u201365.","journal-title":"Inflammation"},{"key":"4289_CR51","doi-asserted-by":"crossref","unstructured":"Tan J et al. Secretome of EMSCs neutralizes LPS\u2013induced acute lung injury via aerosol administration. Int J Mol Med. 2023;52(5).","DOI":"10.3892\/ijmm.2023.5307"},{"issue":"1","key":"4289_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","volume":"14","author":"T Zhou","year":"2021","unstructured":"Zhou T, et al. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14(1):24.","journal-title":"J Hematol Oncol"},{"key":"4289_CR53","doi-asserted-by":"publisher","first-page":"709225","DOI":"10.3389\/fcell.2021.709225","volume":"9","author":"E Ferrini","year":"2021","unstructured":"Ferrini E, et al. Persistency of mesenchymal stromal\/stem cells in lungs. Front Cell Dev Biol. 2021;9:709225.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4289_CR54","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1038\/s41598-021-83894-7","volume":"11","author":"CH Masterson","year":"2021","unstructured":"Masterson CH, et al. Intra-vital imaging of mesenchymal stromal cell kinetics in the pulmonary vasculature during infection. Sci Rep. 2021;11(1):5265.","journal-title":"Sci Rep"},{"issue":"4","key":"4289_CR55","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.bbrc.2014.03.051","volume":"446","author":"M Lee","year":"2014","unstructured":"Lee M, et al. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo. Biochem Biophys Res Commun. 2014;446(4):983\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4289_CR56","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","volume":"40","author":"A Moeller","year":"2008","unstructured":"Moeller A, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40(3):362\u201382.","journal-title":"Int J Biochem Cell Biol"},{"key":"4289_CR57","doi-asserted-by":"crossref","unstructured":"Staley EM et al. Extracorporeal corporeal membrane oxygenation: indications, technical considerations, and future trends. 2022:2022;7.","DOI":"10.21037\/aob-21-85"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04289-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04289-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04289-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T22:05:14Z","timestamp":1743977114000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04289-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4289"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04289-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"University Hospital 12 de Octubre (Madrid, Spain) Ethical Committee and AEMPS Permission number SLC59890178876, to the project entitled \u201cConsecutive IntraBronchial Administration of Wharton\u2019s Jelly-Derived Mesenchymal Stromal Cells in ECMO-Supported Pediatric Patients with End-Stage Interstitial Lung Disease: A Safety and Feasibility Study (CIBA Method)\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and following advice from the European Medicines Agency (EMA) on Advanced Therapy Medicinal Products (ATMP), we obtained informed consent from the patient\u2019s family, and Compassionate Use permission from the Spanish Agency of Medicines and Medical Devices (AEMPS) (Permission number SLC59890178876, August 16, 2023).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"164"}}